Comparative pharmacokinetics [General Sta­tis­tics]

posted by santosh.awale – Mumbai, 2009-01-15 11:24 (6362 d 23:53 ago) – Posting: # 3035
Views: 7,419

Dear ElMaestro and HS sir,
from your reply, i came to know that my data was not sufficient to ans. sponsor claims that his formulation is safe and non-abuse. then what will be statisticle parameter i have to evaluate? if EMEA's definition that a BE study is a comparative BA sudy, then what will be stat. evaluation?

Regards..
Santosh A.

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
153 visitors (0 registered, 153 guests [including 20 identified bots]).
Forum time: 12:17 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5